Comparison of Multiparametric Prostate MRI and Ga-68 PSMA PET Imaging in Prostate Cancer Staging
试验速览
- 阶段
- 不适用
- 发起方
- 入组人数
- 47
- 试验地点
- 2
- 主要终点
- Lesion location
研究概览
简要总结
In this study, it is aimed to compare the lesion location, lesion size, local and distant metastases detection rates of Ga68 PSMA PET and Multiparametric Prostate MR imaging tests used in staging in patients diagnosed with prostate cancer.
The pathologies of the patients who were decided to undergo radical prostatectomy as a treatment will also be compared with the staging tests.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- •diagnosed with prostate cancer
- •Gleason score 7 or above / 6 with high risk
- •No other treatment
排除标准
- •treated with radiotherapy
- •treated with ADT
结局指标
主要结局
Lesion location
时间窗: Between prostate biopsy and curative treatment decision , usually 2 month
Both MRI and PET results will be compared. Lesion location will be defined as "left", "right", "apical", "basal", "midline".
Extraprostatic involvement
时间窗: Between prostate biopsy and curative treatment decision , usually 2 month
Both MRI and PET results will be compared. Involvement will be stated as "exist" , "non-exist".
Lesion Size
时间窗: Between prostate biopsy and curative treatment decision , usually 2 month
Both MRI and PET results will be compared, Lesion size will be stated in milimeters.
Local and distant metastasis
时间窗: Between prostate biopsy and curative treatment decision , usually 2 month
Both MRI and PET results will be compared. Metastasis will be stated as "exist" , "non-exist".
Lymph node involvement
时间窗: Between prostate biopsy and curative treatment decision , usually 2 month
Both MRI and PET results will be compared. Involvement will be stated as "exist", "non-exist".
次要结局
未报告次要终点
研究者
Can Sicimli
Principal Investigator
Gulhane Training and Research Hospital